Cannabis Law Report

NOVEMBER 4, 2021

Drug Enforcement Agency (DEA) to cultivate marijuana for research purposes. In 2016, Dr. Sue Sisley first applied to grow cannabis for research purposes when the Obama administration announced a plan to allow other growers to provide cannabis to researchers. The DEA dragged their feet on this plan for years, so lawsuits were filed.

DEA 52

DEA Clinical Trials Advocacy Legislation 52

Canna Law Blog

JUNE 1, 2019

Drug Enforcement Administration (DEA) when it comes to DEA’s handling of petitions to remove marijuana from the list of most dangerous drugs. Here’s what John Erlichman, a key aid to then-President Nixon, told Harper’s Magazine in 2016: You want to know what this was really all about? You understand what I’m saying?

DEA 98

DEA Marijuana History Cannabis 98

WeedAdvisor

AUGUST 28, 2019

The applications were submitted as far back as 2016. Despite a 90-day deadline for review, the DEA ignored this cut-off and simply sat on the applications for three years. This likely would have been longer, but the DEA had not anticipated a legal threat to force some action. Dozens of Applications”. .

DEA 61

DEA Marijuana History THC 61

Cannabis Law Report

NOVEMBER 11, 2019

You might think it’s California,but actually it is …… According to recently published DEA data about illegal grows it is Kentucky, where both recreational and medical marijuana are still illegal. The DEA confiscated over 1.8 Across the United States, the DEA seized 2.82 million plants in 2017.

DEA 45

DEA Data Recreational Legalization 45

Cannabis Law Report

SEPTEMBER 9, 2019

The DEA’s announcement signals the “beginning of the end” of federal marijuana prohibition, as the policy change allows federal agencies to evaluate and assess the medical use and abuse potential of marijuana with (limited) political interference. BY EMILY BURNS, GREEN LIGHT LAW GROUP —.

DEA 45

DEA Law Policy Safety 45

NORML

MARCH 1, 2019

In August 2016, the US Drug Enforcement Administration announced in the US Federal Register that the agency was “adopting a new policy that is designed to increase the number of entities registered under the Controlled Substances Act to grow (manufacture) marijuana to supply legitimate researchers in the United States.”

DEA 170

DEA Research and Development Clinical Trials Marijuana 170

NORML

JANUARY 17, 2019

As the result of a lawsuit, DEA Administrative Law Judge Mary Ellen Bittner in 2007 ruled that expanding the pool of federally licensed providers would be “in the public interest.” The agency ultimately rejected her decision.

Clinical Trials 230

Clinical Trials Legislation DEA Strains 230

Freedom Leaf

OCTOBER 15, 2018

On September 28, the DEA designated Epidiolex —a plant-based CBD pharmaceutical manufactured by the UK-based GW Pharmaceuticals—a Schedule V drug in the government’s list of controlled substances. schedules were created by the Controlled Substances Act (CSA) in 1970 and are interpreted and enforced by the DEA.

DEA 51

DEA CBD Pharmaceutical Epilepsy 51

NORML

JULY 8, 2021

That’s down 67 percent since 2016, and over 80 percent since 2012 – when Colorado and Washington became the first two states to legalize and regulate the adult-use marijuana market. Just over 1,000 people were sentenced federally in 2020 for violating marijuana trafficking laws.

Law 241

Law Legalization Marijuana DEA 241

The Blunt Truth

OCTOBER 15, 2020

Hemp growers are unhappy over the DEA’s hemp rule. Maine legalized recreational cannabis in 2016. dea hemp rule. The Hemp Industries Association and RE Botanicals are back in court, still unhappy over the DEA’s interim final rule on hemp. New Zealand will vote on recreational cannabis on Saturday.

DEA 95

DEA Hemp Recreational Consumption 95

Cannabis Law Report

MARCH 30, 2022

In 2016, the Agency announced that it would expand the pool of federally licensed growers beyond just the University of Mississippi (which was initially granted a federal cannabis cultivation license in 1968). The full text of S. 253 is online here. Additional information is available from NORML here.

Legislation 95

Legislation Clinical Trials DEA Access 95

Canna Law Blog

SEPTEMBER 15, 2022

The court noted the DEA recently described marijuana as inducing “various psychoactive effects that can lead to behavioral impairment,” and the DEA believed marijuana can “decrease IQ,” and cause problems related to family, school, and work. These “reasons” came from a 2016 DEA denial of a petition to reschedule marijuana.

DEA 81

DEA Marijuana Safety Legislation 81

Veriheal

JULY 29, 2021

The DEA’s push to review cannabis research applications has been anticipated for quite some time. In 2016, the Agency revealed that it would start accepting applications from hopeful growers. Fast forward to 2019 and the DEA unveiled eagerly anticipated plans for cannabis research.

DEA 98

DEA Cannabis Cannabinoids Sativa 98

Cannabis Law Report

MAY 29, 2022

8] Spravato is derived from ketamine and categorized by DEA as a Schedule III controlled substance. DEA and the Controlled Substances Act. In addition to the arduous FDA approval process, potential psychedelic therapies would also require complying with requirements from the Drug Enforcement Administration (DEA). 2] David E.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

APRIL 18, 2019

Sacramento New & Review have detailed the DEA, FBI and IRS investigations and written a piece well worth reading if you want to understand how difficult it is going to be to dig out the entrenched black sector of cannabis in California. It was September 14, 2016.

Banking 55

Banking DEA Legalization Marijuana 55

United Patients Group

APRIL 3, 2023

Epidiolex, an FDA-approved medication containing CBD (cannabidiol), has been listed as Schedule 5 by the DEA since June 25th, 2019. For example, if you live in California where Proposition 64 was passed by voters in 2016 legalizing recreational use of marijuana, no recommendation as long as the patient is 21 years of age and older.

DEA 52

DEA Patients Conditions Cannabis 52

Canna Law Blog

JULY 20, 2020

In 2016, the Drug Enforcement Agency (DEA) announced its intent to make kratom a Schedule I narcotic (alongside heroin, LSD, and cannabis), but it subsequently withdrew that position. Today, the DEA considers kratom to be a “Drug of Concern”, along with other substances like salvia divornum.

Legalization 71

Legalization DEA CBD Decriminalization 71

Canna Law Blog

AUGUST 7, 2023

And it is not on the CSA (the DEA tried and then backed off efforts to schedule it in 2016). When DEA opted not to schedule kratom, a number of states did schedule the substance (and a number went the other way, passing various kratom consumer protection acts ). But, it can be intoxicating.

Cannabinoids 77

Cannabinoids Food DEA CBD 77

NORML

APRIL 8, 2020

As a result, the DEA has been encouraged for over a decade to expand the pool of federally licensed cannabis producers — a move that the agency has largely resisted. In 2016, the agency appeared to reconsider its longstanding policy, and publicly stated for the first time that it would consider additional applicants.

Cultivation 351

Cultivation DEA Clinical Trials Marijuana 351

The Blunt Truth

JUNE 6, 2019

The Blunt Truth started in February 2016, with the slightly crazy idea that a BigLaw firm could talk about marijuana on a regular basis. Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. F irst, a point of personal pride. As of this week, we’ve reached our 300th post.

Banking 40

Banking DEA Food History 40

Cannabis Law Report

JULY 9, 2021

Drug Enforcement Agency (“DEA”). Some physicians and therapists have argued that the Right to Try Act permits them to administer psilocybin to terminally ill patients (since studies are well past the Phase 1 stage), but the DEA has met this with resistance given psilocybin’s status as a Schedule I drug. AIMS Institute, PLLC.

Law 105

Law Therapy Clinical Trials Research and Development 105

The Herb Collective

JUNE 25, 2018

According to Trend Statistics, there are over 2,604,079 medical marijuana patients in 2016, with 19.8 "Every year, about 98% of all of the grass removed by the DEA's "Domestic Cannabis Eradication/Suppression Program" is really hemp." In 2016, sales of marijuana totaled $6.7 Not all drugs have been approved.

Marijuana 56

Marijuana Edibles Recreational Strains 56

Cannabis Law Report

APRIL 1, 2019

The following are highlights of this historic agreement: SIVA will exclusively handle the rewrite of the Controlled Substances Act (CSA), with limited involvement allowed from the different federal agencies, including the FDA, DEA, etc. And in 2016 he comes in at 3:22 on this video. Their erstwhile leader is to be found on Linked in.

DEA 60

DEA Programs History Education 60

Cannabis Law Report

JANUARY 30, 2019

To expand the number of manufacturers, the Drug Enforcement Administration (DEA) submitted a notice in the Federal Register on August 11, 2016, soliciting applications for licenses to manufacture marijuana for research purposes. However, over two years have passed without any new schedule I marijuana manufacturer registrations.

Research and Development 63

Research and Development DEA CBD Law 63

Canna Law Blog

OCTOBER 23, 2020

Drug Enforcement Administration (“DEA”) to reschedule marijuana. As we all know, the DEA has routinely refused to accept or denied each and every petition, minus one that yielded very specific changes for a synthetic cannabis drug. Per the usual course, the DEA filed a motion to dismiss for failure to exhaust administrative remedies.

DEA 70

DEA Policy History Treatment 70

Canna Law Blog

SEPTEMBER 28, 2019

Not long ago we wrote about a decision by the Second Circuit that may force the DEA to re- or deschedule marijuana after writing about the lawsuit when it was first filed last year. In 2016, the Albuquerque Public Schools (“APS”) informed Mother that Student could not receive cannabis oil on school grounds.

Education 61

Education Oil DEA Cannabis 61

Cannabis Law Report

OCTOBER 31, 2019

Balagia’s initial defense attorney, Daphne Silverman, said in court filings that Morgan was working for the DEA as a secret informant whose job it was to lure Colombian fugitives to the U.S. agencies like the FBI, DEA and Homeland Security Investigations, according to court documents. by getting them to cooperate.

DEA 49

DEA History Legalization Marijuana 49

SMPL

AUGUST 14, 2019

ABA noted that the Drug Enforcement Administration (DEA) announced in 2016 that it is accepting applications for additional cannabis manufacturers, which could bolster research, for example. One area that could be quickly improved is in the sourcing of research-grade marijuana.

Policy 40

Policy Research and Development Marijuana DEA 40

Canna Law Blog

FEBRUARY 2, 2020

The law was modified in 2016 in House Bill 992. The Commission is also concerned about “inevitable delays in laboratory results because of high sample volumes” which are exacerbated by the interim hemp rules’ requirement that labs testing hemp to obtain DEA registration.

Hemp 103

Hemp CBD Agriculture Cultivation 103

Cannabis Law Report

JANUARY 13, 2022

Department of Justice Drug Enforcement Administration (DEA) suggesting that cannabinoids synthetically produced from non-cannabis materials, including delta-8 THC, are controlled under the federal Controlled Substances Act as a “tetrahydrocannabinol.” total tetrahydrocannabinols (THC).”. 16 In the Weeds article) from the U.S.

Dispensary 52

Dispensary Law Concentrates DEA 52

Canna Law Blog

AUGUST 31, 2023

This all looks pretty good right now, but the Drug Enforcement Administration (DEA) and ultimately the Attorney General (AG) have final say on whether to schedule or reschedule marijuana following the HHS recommendation. In any case, the DEA Administrator reports to the AG (through the Deputy AG). The AG could then reschedule.

DEA 116

DEA Marijuana Banking Research and Development 116

PrestoDoctor

JULY 16, 2019

Since 2016 the Cannabis Cultural Association (CCA) has helped marginalized and underrepresented communities engage in the legal cannabis industry, emphasizing criminal justice reform, access to medical cannabis, and adult use legalization. The case now remains in the DEA’s hands until further notice.

Policy 40

Policy DEA Access Media 40

PrestoDoctor

JULY 16, 2019

Since 2016 the Cannabis Cultural Association (CCA) has helped marginalized and underrepresented communities engage in the legal cannabis industry, emphasizing criminal justice reform, access to medical cannabis, and adult use legalization. The case now remains in the DEA’s hands until further notice.

Policy 40

Policy DEA Access Media 40

Canna Law Blog

MAY 7, 2020

Ole Miss got the cannabis study and research cultivation gig from the DEA (via a contract with the National Institute on Drug Abuse (NIDA)) in 1968. In 2016, the DEA finally shifted to different treatment around expanded research efforts into cannabis beyond Ole Miss.

DEA 71

DEA Research and Development Cultivation Supply Chain 71

Canna Law Blog

SEPTEMBER 6, 2023

Many people in the cannabis industry are convinced that this HHS recommendation to the Drug Enforcement Administration (DEA) means that the DEA will undertake this rescheduling (and fairly quickly, too–which would be a huge departure from its refusal to reschedule back in 2016). Just my two cents; feel free to disagree.

Research and Development 113

Research and Development DEA Marijuana Pharmaceutical 113

CannaMD

MAY 6, 2020

In practice, the chances of feds or the DEA sitting at the border waiting to catch someone – that’s just not happening. For more information, see: The Arkansas Medical Marijuana Amendment of 2016. As attorney Allison Malsbury explains: From a legal perspective, it’s very cut and dried. Possession Limit: 2.5

Hash 103

Hash Legalization Marijuana Concentrates 103

CannaMD

SEPTEMBER 15, 2020

SHORT ANSWER: In November 2016, the Florida Medical Marijuana Legalization Initiative (known as Amendment 2 ) legalized medical marijuana treatment in Florida. In March, 2016, State Bill 307 expanded access to full-strength medical marijuana to terminally ill patients who were determined by two doctors to have less than a year to live.

Law 126

Law Marijuana Patients Treatment 126